A physiologically-based flow network model for hepatic drug elimination III: 2D/3D DLA lobule models

Abstract

BackgroundOne of the major issues in current pharmaceutical development is potential hepatotoxicity and drug-induced liver damage. This is due to the unique metabolic processes performed in the liver to prevent accumulation of a wide range of chemicals in the blood. Recently, we developed a physiologically-based lattice model to address the transport and metabolism of drugs in the liver lobule (liver functional unit).MethodIn this paper, we extend our idealized model to consider structural and spatial variability in two and three dimensions. We introduce a hexagonal-based model with one input (portal vein) and six outputs (hepatic veins) to represent a typical liver lobule. To capture even more realistic structures, we implement a novel sequential diffusion-limited aggregation (DLA) method to construct a morphological sinusoid network in the lobule. A 3D model constructed with stacks of multiple 2D sinusoid realizations is explored to study the effects of 3D structural variations. The role of liver zonation on drug metabolism in the lobule is also addressed, based on flow-based predicted steady-state O2 profiles used as a zonation indicator.ResultsWith this model, we analyze predicted drug concentration levels observed exiting the lobule with their detailed distribution inside the lobule, and compare with our earlier idealized models. In 2D, due to randomness of the sinusoidal structure, individual hepatic veins respond differently (i.e. at different times) to injected drug. In 3D, however, the variation of response to the injected drug is observed to be less extreme. Also, the production curves show more diffusive behavior in 3D than in 2D.ConclusionAlthough, the individual producing ports respond differently, the average lobule production summed over all hepatic veins is more diffuse. Thus the net effect of all these variations makes the overall response smoother. We also show that, in 3D, the effect of zonation on drug production characteristics appears quite small. Our new biophysical structural analysis of a physiologically-based 3D lobule can therefore form the basis for a quantitative assessment of liver function and performance both in health and diseaseElectronic supplementary materialThe online version of this article (doi:10.1186/s12976-016-0034-5) contains supplementary material, which is available to authorized users.

Zonation of hepatic fat accumulation: insights from mathematical modelling of nutrient gradients and fatty acid uptake

“…In the past, computational models were used to understand the zonation pattern of processes involved in the detoxification of xenobiotics and drugs, e.g. [36][37][38][39]. However, only a few mathematical models exist, which consider explicitly aspects of the zonation of hepatic core metabolism.…”

Order Through Disorder: The Characteristic Variability of Systems

“…This model supports the fact that individual ports react in different ways, and that the typical liver lobule production over all the hepatic veins is more diffuse. The overall impact of these alterations is associated with a smoother drug response (Rezania et al, 2016).…”

Liver Bioreactor Design Issues of Fluid Flow and Zonation, Fibrosis, and Mechanics: A Computational Perspective

“…To summarize many of the concepts outlined in this review, we now present some simple simulations of fluid flow and mechanics at the lobule scale, based on our earlier work [230][231][232]. (A): Figure 1 shows our basic conceptual unit.…”

“…As the resulting oxygen distribution is believed to affect the zonal expression of CYP enzymes, we utilized the steady state O 2 distributions to estimate fibrosis modifications of drug-metabolizing (paclitaxel) enzymes across the lobule. Here, we followed the protocol outlined in our earlier paper [232] to calculate these zonal distributions.…”